According to WiseGuy Reports, the Microcrystalline Cellulose as Pharmaceutical Excipient Market stood at USD 1,200 Million in 2024 and increased to USD 1,300 Million in 2025. Revenue is forecast to reach USD 2,500 Million by 2035, representing a CAGR of 6.6% during 2026–2035. Expanding drug formulation activity, increased generic and biosimilar production, pharmaceutical R&D...